These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6325410)

  • 1. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells.
    Schneider J; Huh MM; Bradlow HL; Fishman J
    J Biol Chem; 1984 Apr; 259(8):4840-5. PubMed ID: 6325410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation.
    Vandewalle B; Lefebvre J
    Mol Cell Endocrinol; 1989 Feb; 61(2):239-46. PubMed ID: 2537243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol estrogen formation in MCF-7 cell culture and effects of bromoestrogen inhibitors.
    Brueggemeier RW; Katlic NE; Palmer CW; Stevens JM
    Mol Cell Endocrinol; 1989 Jul; 64(2):161-7. PubMed ID: 2551756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for the mechanism of estrogen-induced carcinogenesis.
    Zhu BT; Bui QD; Weisz J; Liehr JG
    Endocrinology; 1994 Nov; 135(5):1772-9. PubMed ID: 7956900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estradiol metabolites on the susceptibility of low density lipoprotein to oxidation.
    Seeger H; Mueck AO; Lippert TH
    Life Sci; 1997; 61(9):865-8. PubMed ID: 9284079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity.
    Barnea ER; MacLusky NJ; Naftolin F
    Steroids; 1983 May; 41(5):643-56. PubMed ID: 6658896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological effect of estrogen metabolites in human breast cancer].
    Imoto S
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):505-17. PubMed ID: 1614394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholestrogens are MCF-7 cell estrogen receptor agonists.
    Schütze N; Vollmer G; Tiemann I; Geiger M; Knuppen R
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):781-9. PubMed ID: 8274412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites.
    Zhu BT; Roy D; Liehr JG
    Endocrinology; 1993 Feb; 132(2):577-83. PubMed ID: 8381068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells.
    Gupta M; McDougal A; Safe S
    J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):413-9. PubMed ID: 10030690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine characteristics of human breast epithelial cells, MCF-10F.
    Singhal H; Guo L; Bradlow HL; Mittelman A; Tiwari RK
    Horm Res; 1999; 52(4):171-7. PubMed ID: 10725782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization.
    Swaneck GE; Fishman J
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):7831-5. PubMed ID: 3186693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT; Pento JT; Magarian RA
    Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro O-methylation of 4-hydroxyestrone monosulfates.
    Shimada K; Yumura Y; Nambara T
    J Pharmacobiodyn; 1982 Jun; 5(6):448-50. PubMed ID: 7120041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direction of estradiol metabolism as a control of its hormonal action--uterotrophic activity of estradiol metabolites.
    Martucci C; Fishman J
    Endocrinology; 1977 Dec; 101(6):1709-15. PubMed ID: 590186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors.
    Merriam GR; MacLusky NJ; Picard MK; Naftolin F
    Steroids; 1980 Jul; 36(1):1-11. PubMed ID: 7426122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.